3.7. Determination of the Most Valuable Indicator for the Detection of HER2 Overexpression in Metastatic Axillary Lymph Nodes Using [99mTc] Tc-ADAPT6 in Breast Cancer Patients. Here, ERBB2 is linked to breast cancer.